{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:14:57Z","timestamp":1790648097502,"version":"4.1.0"},"reference-count":53,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2010,9,3]],"date-time":"2010-09-03T00:00:00Z","timestamp":1283472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The absence of herd immunity to orthopoxviruses and the concern that variola or monkeypox viruses could be used for bioterroristic activities has stimulated the development of therapeutics and safer prophylactics. One major limitation in this process is the lack of accessible human orthopoxvirus infections for clinical efficacy trials; however, drug licensure can be based on orthopoxvirus animal challenge models as described in the \u201cAnimal Efficacy Rule\u201d. One such challenge model uses ectromelia virus, an orthopoxvirus, whose natural host is the mouse and is the etiological agent of mousepox. The genetic similarity of ectromelia virus to variola and monkeypox viruses, the common features of the resulting disease, and the convenience of the mouse as a laboratory animal underscores its utility in the study of orthopoxvirus pathogenesis and in the development of therapeutics and prophylactics. In this review we outline how mousepox has been used as a model for smallpox. We also discuss mousepox in the context of mouse strain, route of infection, infectious dose, disease progression, and recovery from infection.<\/jats:p>","DOI":"10.3390\/v2091918","type":"journal-article","created":{"date-parts":[[2010,9,19]],"date-time":"2010-09-19T09:41:46Z","timestamp":1284889306000},"page":"1918-1932","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Ectromelia Virus Infections of Mice as a Model to Support the Licensure of Anti-Orthopoxvirus Therapeutics"],"prefix":"10.3390","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1079-0988","authenticated-orcid":false,"given":"Scott","family":"Parker","sequence":"first","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, 1100 S. Grand Blvd., St. Louis, MO, 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbar M.","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, 1100 S. Grand Blvd., St. Louis, MO, 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Painter","sequence":"additional","affiliation":[{"name":"Chimerix Inc., 2505 Meridian Park Way, Suite 340, Durham, NC, 27713, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Schriewer","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, 1100 S. Grand Blvd., St. Louis, MO, 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Mark","family":"Buller","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, 1100 S. Grand Blvd., St. Louis, MO, 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2010,9,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/path.1700330317","article-title":"Infectious ectromelia. A hitherto undescribed virus disease in mice","volume":"33","author":"Marchal","year":"1930","journal-title":"J. Pathol. Bacteriol."},{"key":"ref_2","first-page":"553","article-title":"Mousepox (infectious ectromelia): past, present, and future","volume":"31","author":"Fenner","year":"1981","journal-title":"Lab. Anim. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/mr.55.1.80-122.1991","article-title":"Poxvirus pathogenesis","volume":"55","author":"Buller","year":"1991","journal-title":"Microbiol.Rev."},{"key":"ref_4","unstructured":"Buller, R.M.L., and Fenner, F. (2007). The mouse in biomedical research, Elsevier."},{"key":"ref_5","first-page":"602","article-title":"Mousepox outbreak in laboratory mouse colony","volume":"46","author":"Dick","year":"1996","journal-title":"Lab. Anim. Sci."},{"key":"ref_6","first-page":"319","article-title":"Variable resistance to ectromelia (mousepox) virus among genera of Mus","volume":"127","author":"Buller","year":"1986","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2217\/17460794.3.6.595","article-title":"Therapeutic and prophylactic drugs to treat orthopoxvirus infections","volume":"3","author":"Parker","year":"2008","journal-title":"Future Virology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(48)91599-2","article-title":"The pathogenesis of the acute exanthems; an interpretation based on experimental investigations with mousepox; infectious ectromelia of mice","volume":"2","author":"Fenner","year":"1948","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1099\/vir.0.81090-0","article-title":"Ectromelia virus: the causative agent of mousepox","volume":"86","author":"Esteban","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1073\/pnas.0402949101","article-title":"Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox","volume":"101","author":"Chaudhri","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Fang, M., Lanier, L.L., and Sigal, L.J. (2008). A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.0040030"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/978-1-60761-362-6_28","article-title":"Studying NK cell responses to ectromelia virus infections in mice","volume":"612","author":"Fang","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.4049\/jimmunol.175.10.6829","article-title":"Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus","volume":"175","author":"Fang","year":"2005","journal-title":"J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-2427(98)00086-5","article-title":"Type 1 and type 2 cytokines in antiviral defense","volume":"63","author":"Karupiah","year":"1998","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1128\/JVI.00115-06","article-title":"Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function","volume":"80","author":"Panchanathan","year":"2006","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1128\/JVI.02061-06","article-title":"Induction of natural killer cell responses by ectromelia virus controls infection","volume":"81","author":"Parker","year":"2007","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1099\/vir.0.83205-0","article-title":"Primary naive and interleukin-2-activated natural killer cells do not support efficient ectromelia virus replication","volume":"89","author":"Parker","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1128\/JVI.00427-06","article-title":"Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB\/c mice","volume":"80","author":"Tscharke","year":"2006","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.4049\/jimmunol.0803985","article-title":"IL-12p40 and IL-18 play pivotal roles in orchestrating the cell-mediated immune response to a poxvirus infection","volume":"183","author":"Wang","year":"2009","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1086\/301735","article-title":"Comparative genetics of resistance to viruses","volume":"62","author":"Brownstein","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.1128\/jvi.66.12.7073-7079.1992","article-title":"Serial backcross analysis of genetic resistance to mousepox, using marker loci for Rmp-2 and Rmp-3","volume":"66","author":"Brownstein","year":"1992","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1128\/jvi.69.11.6958-6964.1995","article-title":"Chromosome mapping of Rmp-4, a gonad-dependent gene encoding host resistance to mousepox","volume":"69","author":"Brownstein","year":"1995","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1128\/jvi.69.9.5875-5877.1995","article-title":"Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype","volume":"69","author":"Delano","year":"1995","journal-title":"J. Virol."},{"key":"ref_24","unstructured":"Fenner, F., Henderson, D.A., Arita, I., Jezek, Z., and Ladnyi, I.D. (1988). Smallpox and its eradication, World Health Organisation."},{"key":"ref_25","first-page":"451","article-title":"Histopathogenesis of mousepox. I. Respiratory infection","volume":"43","author":"Roberts","year":"1962","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/17460913.2.1.17","article-title":"Human monkeypox: an emerging zoonotic disease","volume":"2","author":"Parker","year":"2007","journal-title":"Future Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1586\/14787210.4.2.277","article-title":"Smallpox antiviral drug development: satisfying the animal efficacy rule","volume":"4","author":"Jordan","year":"2006","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2217\/17460794.1.2.173","article-title":"The challenge of developing an antiviral agent for the treatment of smallpox using the animal efficacy rule","volume":"1","author":"Painter","year":"2006","journal-title":"Future Virology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virol.2008.11.015","article-title":"Mousepox in the C57BL\/6 strain provides an improved model for evaluating anti-poxvirus therapies","volume":"385","author":"Parker","year":"2009","journal-title":"Virology"},{"key":"ref_30","first-page":"16","article-title":"Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. II. Pathogenesis","volume":"37","author":"Jacoby","year":"1987","journal-title":"Lab. Anim. Sci."},{"key":"ref_31","unstructured":"Parker, S., and Buller, R.M. (2010). Mousepox disease is dependent on route of infection."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11084","DOI":"10.1128\/JVI.00423-07","article-title":"Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox","volume":"81","author":"Adams","year":"2007","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1073\/pnas.0405954101","article-title":"Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox","volume":"101","author":"Jahrling","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref_35","first-page":"543","article-title":"The response of mice to large intravenous injections of ectromelia virus. II. The growth of virus in the liver","volume":"40","author":"Mims","year":"1959","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1016\/j.molimm.2008.08.054","article-title":"The interaction between the host\u2019s complement system and the poxviral complement regulatory protein determines the lethality of ectromelia infection","volume":"45","author":"Moulton","year":"2008","journal-title":"Molecular Immunology"},{"key":"ref_37","first-page":"63","article-title":"Air sampling to recover variola virus in the environment of a smallpox hospital","volume":"25","author":"Meiklejohn","year":"1961","journal-title":"Bull. World Health Organisation"},{"key":"ref_38","first-page":"615","article-title":"The recovery of smallpox virus from patients and their environment in a smallpox hospital","volume":"33","author":"Downie","year":"1965","journal-title":"Bull. World Health Organisation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/713610418","article-title":"An epidemiological analysis of the 1971 smallpox outbreak in Aralsk, Kazakhstan","volume":"29","author":"Zelicoff","year":"2003","journal-title":"Crit Rev. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/135965350801300703","article-title":"Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001","volume":"13","author":"Parker","year":"2008","journal-title":"Antivir. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nbt1007-1084","article-title":"The FDA animal efficacy rule and biodefense","volume":"25","author":"Gronvall","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2007.08.003","article-title":"Efficacy of therapeutic intervention with an oral ether-lipid analogue of cidofovir (CMX001) in a lethal mousepox model","volume":"77","author":"Parker","year":"2008","journal-title":"Antiviral Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.00879-06","article-title":"Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice","volume":"51","author":"Quenelle","year":"2007","journal-title":"Antimicrob.Agents Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/587668","article-title":"Severe eczema vaccinatum in a household contact of a smallpox vaccinee","volume":"46","author":"Vora","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_45","unstructured":"(2009). CDC, Progressive vaccinia in a military smallpox vacinee - United States. MMWR Morb. Mortal. Wkly. Rep., 58, 1\u20134."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/315190","article-title":"Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge","volume":"181","author":"Bray","year":"2000","journal-title":"J. Infec. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/AAC.48.6.2267-2273.2004","article-title":"Efficacy of cidofovir in a murine model of disseminated progressive vaccinia","volume":"48","author":"Neyts","year":"2004","journal-title":"Antimicrob Agents Chemother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1086\/422696","article-title":"Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice","volume":"190","author":"Smee","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1073\/pnas.0912134107","article-title":"Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice","volume":"107","author":"Grosenbach","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1128\/AAC.00762-07","article-title":"Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses","volume":"51","author":"Quenelle","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/JVI.02012-09","article-title":"A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus","volume":"84","author":"Stabenow","year":"2010","journal-title":"J. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.09.55","article-title":"The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks","volume":"8","author":"Handley","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/JVI.75.3.1205-1210.2001","article-title":"Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox","volume":"75","author":"Jackson","year":"2001","journal-title":"J Virol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/2\/9\/1918\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:03:18Z","timestamp":1760220198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/2\/9\/1918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,3]]},"references-count":53,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2010,9]]}},"alternative-id":["v2091918"],"URL":"https:\/\/doi.org\/10.3390\/v2091918","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,3]]}}}